RPG Life Sciences (NSE:RPGLIFE) Other Current Receivables: ₹106 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:RPGLIFE RPG Life Sciences Ltd NSE:RPGLIFE
89 GF Score
Price ₹2,937.00
GF Value ₹2,367.10
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is RPG Life Sciences Other Current Receivables?

RPG Life Sciences NSE:RPGLIFE +1.19% 89 Other Current Receivables is ₹106 Mil as of Mar. 2026. GuruFocus rates NSE:RPGLIFE with a GF Score™ of 89/100 and a GF Value™ of ₹2,367.10 (Modestly Overvalued). The stock has 5 warning signs investors should review.

RPG Life Sciences's Other Current Receivables for the quarter that ended in Mar. 2026 was ₹106 Mil.

RPG Life Sciences's quarterly Other Current Receivables stayed the same from Sep. 2025 (₹0.00 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹105.90 Mil).

RPG Life Sciences's annual Other Current Receivables increased from Mar. 2024 (₹18.10 Mil) to Mar. 2025 (₹76.60 Mil) and increased from Mar. 2025 (₹76.60 Mil) to Mar. 2026 (₹105.90 Mil).

RPG Life Sciences Other Current Receivables Related Terms

RPG Life Sciences Other Current Receivables Historical Data

* Premium members only.

The historical data trend for RPG Life Sciences's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RPG Life Sciences Other Current Receivables Chart

RPG Life Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.80 14.60 18.10 76.60 105.90

RPG Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.60 0.00 0.00 0.00 105.90
NSE:RPGLIFE
89GF Score
RPG Life Sciences Ltd NSE:RPGLIFE
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RPG Life Sciences Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹106 Mil mean?
RPG Life Sciences (NSE:RPGLIFE) has a Other Current Receivables of ₹106 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on RPG Life Sciences and its competitors.
Is RPG Life Sciences' Other Current Receivables too high?
RPG Life Sciences' current Other Current Receivables is ₹106 Mil. Overall, RPG Life Sciences has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RPG Life Sciences' Other Current Receivables compare to ZTS and UTHR?
RPG Life Sciences' Other Current Receivables of ₹106 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on RPG Life Sciences and its competitors. RPG Life Sciences's current Other Current Receivables is ₹106 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RPG Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RPG Life Sciences (NSE:RPGLIFE) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,367.10, compared to a current price of ₹2,937.00 — trading 24.1% above its estimated fair value. The current Other Current Receivables is ₹106 Mil. RPG Life Sciences' overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For RPG Life Sciences (NSE:RPGLIFE), the current Other Current Receivables is ₹106 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, RPG Life Sciences stock appears to be overvalued. The current stock price of ₹2,937.00 is trading 24.1% above its estimated GF Value™ of ₹2,367.10. GuruFocus considers RPG Life Sciences to be Modestly Overvalued.

Key valuation signals for NSE:RPGLIFE:

  • Other Current Receivables: ₹106 Mil
  • GF Value™: ₹2,367.10 vs. price of ₹2,937.00 (24.1% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RPG Life Sciences Business Description

Other Exchanges 532983:India
Address 463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
89GF Score

Get the complete analysis for NSE:RPGLIFE

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,937.00
Price
₹2,367.10
GF Value